Inactivation of p53 Is Sufficient to Induce Development of Pulmonary Hypertension in Rats.
Pulmonary artery smooth muscle cells (PA-SMCs) in pulmonary arterial hypertension (PAH) show similarities to cancer cells. Due to the growth-suppressive and pro-apoptotic effects of p53 and its inactivation in cancer, we hypothesized that the p53 pathway could be altered in PAH. We therefore explore...
Main Authors: | S Jacquin, V Rincheval, B Mignotte, S Richard, M Humbert, O Mercier, A Londoño-Vallejo, E Fadel, S Eddahibi |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4488287?pdf=render |
Similar Items
-
The beneficial effect of suramin on monocrotaline-induced pulmonary hypertension in rats.
by: Mohamed Izikki, et al.
Published: (2013-01-01) -
Key role of the endothelial TGF-β/ALK1/endoglin signaling pathway in humans and rodents pulmonary hypertension.
by: Benoît Gore, et al.
Published: (2014-01-01) -
Anorexigen-induced pulmonary hypertension and the serotonin (5-HT) hypothesis: lessons for the future in pathogenesis
by: Adnot Serge, et al.
Published: (2002-01-01) -
Acute decompensated pulmonary hypertension
by: Laurent Savale, et al.
Published: (2017-11-01) -
Partial p53 reactivation is sufficient to induce cancer regression
by: Boris Klimovich, et al.
Published: (2022-03-01)